Ведение женщин в пери- и постменопаузе: практические рекомендации / Под ред. В.П. Сметник, Л.М. Ильиной. — М.: Ярославль: ООО «ИПК «Литера», 2010. — 221 с.
Santen P.J., Allred D.C., Androin S.P. et al. Postmenopausal hormone therapy: an Endocrine Society Scientific Statement // J. Clin. Endocrinol. Metab. — 2010. — Vol. 95. — Suppl. 1. — P. 1–66.
Sturdee D.W., Panay N. (Writing Group). Recommendations for the management of postmenopausal vaginal atrophy // J. Climacteric. — 2010. — Vol. 13. — P. 509–522.
Sturdee D.W., Pines A., Archer D.F., Baber D.F. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health // J. Climacteric. — 2011. — Vol. 14. — P. 302–320.
Liao S., Li J., Wei W. et al. Association between diabetes mellitus and breast cancer risk: a metaanalysis of the literature // Asian Рас. J. Cancer Prev. — 2011. — Vol. 12. — P. 1061–1065.
Rees М., Peres-Lopez F.R., Ceasu I. et al. EMAS clinical guide: low-dose vaginal estrogen for postmenopausal vaginal atrophy // Maturitas. — 2012. — Vol. 73. — P. 171–174.
The North American Menopause Society. The 2012 hormone therapy position statement of: The North American Menopause Society // Menopause. — 2012. — Vol. 19. — P. 257–271.
Cagnacci A., Cannoletta М., Palma F. et al. Menopausal symptoms and risk factors for cardiovascular disease in postmenopause // J. Climacteric. — 2012. — Vol. 15. — P. 157–162.
Harlow S.D., Gass М., Hall J.H. et al. Executive Summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging// J. Climacteric. — 2012. — Vol. 15. — P. 105–114.
De Villiers T.J., Pines A., Panay N. et al. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health // J. Climacteric. — 2013. — Vol. 16. — P. 316–337.
Position Statement Management of symptomatic vulvovaginal atrophy: 2013 position statement of the North American Menopause Society // J. Menopause. — 2013. — Vol. 20. — №9. — P. 888– 902.
Pickar J.H. Emerging therapies for postmenopausal vaginal atrophy // Maturitas. — 2013. — Vol. 75. — P. 3–6.
Panay N., Hamoda H., Arya R. et al. The 2013 British Menopause Society, Women Health Concern recommendation on hormone replacement therapy // Menopause Int. — 2013. — Vol. 19. — №2. — P. 59–68.
Genazzani A.R., Schmelter Т., Schaefers M. et al. One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17P-estradiol in postmenopausal women // Climacteric. — 2013. — Vol. 16. — P. 490–498.
De Villiers T.J., Gass M.L., Haines C.J. et al. Global Consensus Statement on Menopausal Hormone Therapy // Climacteric. — 2013. — Vol. 16. — P. 203–204.
Matsui S., Yasui Т., Tani A. et al. Effect of ultra-low-dose estradiol and dydrogesterone on arterial stiffness in postmenopausal women // J. Climacteric. — 2014. — Vol. 17. — P. 191–196.
Archer D.F., Schmelter Th., Schaefers M. et al. A randomized, doubleblind, placebo-controlled study of the lowest effective dose of drospirenone with 17p-estradiol for moderate to severe vasomotor symptoms in postmenopausal women // Menopause. — 2014. — Vol. 21. — №3. — P. 227–235.
Practice Bulletin No. 141: Management of Menopausal Symptoms // Obstet. Gynecol. — 2014. — Vol. 123. — P. 202–216.
Wierman M.E., Arit W., Basson R. et al. Androgen therapy in women: a reappraisal: an Endocrine Society Clinical Practice Guideline // J. Clin. Endocrinol. Metab. — 2014. — Vol. 95. — P. 3489– 3510.
Shifren J.L., Gass M.L.S. (Working Group). Recommendations for clinical care of midlife women (The North American Menopause Society) // J. Menopause. — 2014. — Vol. 21. — №10). — P. 1038–1062.
Portman D.J., Gass M.L.S. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society // J. Menopause. — 2014. — Vol. 21. — №10. — P. 1063– 1068.